AbbVie's Allergan and Evolus have been locked in a yearslong trade secrets fight involving the two drugmakers' South Korean partners and blockbuster Botox. Despite some early promise for Evolus, a U.S ...

Allergan has been more than willing to do whatever necessary to protect its secret process for making blockbuster Botox. After filing a trade theft investigation against a competitor, the drugmaker ...

U.S. District Judge Eli Richardson in Nashville, Tennessee, ruled, opens new tab that Allergan plausibly alleged that Revance had acquired and used some of its rival’s trade secrets amid a series of ...

Facing competition for the world's top-selling drug, AbbVie is jumping on this year's pharmaceutical merger bandwagon with a $63 billion bid for Botox maker Allergan that's meant to spur future growth ...

For Allergan Inc., a subtle offense has proved the best defense in the court of public opinion over Botox. Observers give the Irvine drug maker good marks for its strategy in support of Allergan’s ...

An upstart company with a competitor to Allergan Plc’s Botox has its eye on becoming the next wrinkle treatment of choice. Evolus Inc. has already reached 2,000 doctors with a new app and plans to ...

Irvine-based Allergan Inc., maker of wrinkle-fighting Botox and other drugs, is gaining more attention on Wall Street. At least one analyst even crafted a pun—intended or otherwise—to lay out a case ...

CHICAGO (Reuters) - Allergan Inc said on Thursday that its popular Botox facial wrinkle-smoother worked as a treatment for adults suffering from chronic migraines, according to late-stage clinical ...

In his corner office, Mr. Botox looked his age. He hadn’t had a shot of botulinum toxin in a while, and the furrow between his brows was back. “You would never know I’m really 75 years old,” David E.I ...

Allergan Inc. reported a 21% jump in third-quarter net income Monday on higher sales of the company’s anti-wrinkle drug, Botox. The Irvine-based company had net income of $92 million, or 70 cents a ...

Drugmaker AbbVie said Tuesday it would buy Botox maker Allergan for about $63 billion, grabbing control of by far the biggest name in medical aesthetics to help reduce its reliance on blockbuster ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...